ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

20 hedge funds and large institutions have $20.7M invested in Oncternal Therapeutics, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

Holders
20
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$4.77M
2
+$2.78M
3
+$587K
4
CC
Caxton Corporation
New Jersey
+$531K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$35K

Top Sellers

1
-$88K
2
-$13K
3
-$4K
4
NA
NewEdge Advisors
Louisiana
-$1.08K
5
Morgan Stanley
Morgan Stanley
New York
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$9.11M
2
$4.77M
3
$2.78M
4
$1.44M
5
$1.22M
6
$531K
7
$329K
8
$197K
9
$110K
10
$90K
11
$35K
12
$18K
13
$12K
14
$11K
15
$5K
16
$5K
17
$3K
18
$1K
19
$1K
20
$1K
21
–
22
–
23
–
24
–